What AI agents think about this news
Waste Management's high valuation (34x P/E) is a major concern, with risks including Stericycle integration, cyclical nature of waste volumes, and potential margin compression in a recession. However, the company's pricing power, defensive nature, and strong cash flows are attractive.
Risk: Integration risk and dilution from Stericycle, cyclical nature of waste volumes, and potential margin compression in a recession.
Opportunity: Strong cash flows, defensive nature, and potential for margin expansion.
Key Points
Waste Management's revenue grew 7.1% to $6.31 billion in its most recently reported quarter.
The company's full-year adjusted operating EBITDA margin exceeded 30% for the first time last year.
The stock commands a premium valuation, leaving little margin of safety.
- 10 stocks we like better than WM ›
It has been a turbulent start to 2026 for many investors. As of this writing, the S&P 500 is down about 5% year to date. But amid this broader market weakness, shares of Waste Management (NYSE: WM) have been a bright spot.
The environmental services giant's stock is up more than 5% so far this year. And it's easy to see why investors have flocked to the shares. The company provides an essential service, generates massive cash flow, and routinely rewards its shareholders with dividend increases -- a compelling value proposition during times of uncertainty.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Is the stock's recent outperformance a sign it's time to buy? Or has the market already fully priced in the company's strong fundamental execution?
A resilient business model
Waste Management's latest quarterly update showed a business that is navigating the current macroeconomic environment with ease.
In Q4, the company's revenue reached $6.31 billion -- up 7.1% year over year. A significant portion of this top-line jump was driven by robust pricing power in its collection and disposal business, as well as a meaningful boost from its recent acquisition of Stericycle. Now operating as WM Healthcare Solutions, the newly integrated business contributed $615 million to the company's fourth-quarter revenue.
But what is perhaps more impressive than Waste Management's revenue growth is its expanding profitability. The company's adjusted operating earnings before interest, taxes, depreciation, and amortization (EBITDA) margin expanded to 31.3% in Q4 -- up from 28.9% in the year-ago period. Further highlighting this operational efficiency, the adjusted operating EBITDA margin for its legacy business expanded 150 basis points to 31.5% for the full year.
In addition, Waste Management's total adjusted operating EBITDA surged 15.5% last year. Even more, the company's full-year adjusted operating EBITDA margin exceeded 30% for the first time in its history.
And this operational efficiency is translating directly into cash generation.
The company's free cash flow, or its cash flow from operations less capital expenditures, jumped nearly 27% last year to $2.94 billion. In addition, WM's bottom line remains robust, with Q4 earnings per share coming in at $1.83 -- up sharply from $1.48 in the year-ago period.
A dependable dividend
For income-focused investors, Waste Management's ability to consistently generate cash supports a very reliable dividend.
The company's board of directors recently indicated its intention to increase the annual dividend to $3.78 per share. At the stock's current price, that yields about 1.5%.
While a 1.5% yield might not seem significant at first glance, the payout is incredibly secure. Waste Management's payout ratio sits at about 50%, meaning the company is distributing only about half of its adjusted earnings to shareholders as dividends. This leaves plenty of wiggle room for management to continue increasing the payout in the coming years, even while funding its robust capital expenditures plans.
Where it gets challenging
So, the business is growing, margins are expanding, and the dividend is safe. Why not buy the stock today?
The primary hurdle is valuation. As of this writing, Waste Management trades at a price-to-earnings ratio of about 34.
For a mature, capital-intensive business in the waste and recycling sector, that is a steep premium. At this valuation, the stock arguably already prices in a successful integration of its recent acquisitions and continued margin expansion over time. These are, of course, possible outcomes. But I'd rather wait to see if I can buy the stock when best-case scenarios already seem largely priced in.
Put simply, the stock may be priced for perfection today.
Waste Management is undoubtedly an exceptional business with a durable competitive advantage. And for investors who already own the stock, the safe dividend and strong cash flow make it a great company to hold through market volatility. But for those looking to deploy fresh capital, I believe the lack of a margin of safety makes the stock more of a hold than a buy right now.
Should you buy stock in WM right now?
Before you buy stock in WM, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and WM wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $494,747!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,094,668!*
Now, it’s worth noting Stock Advisor’s total average return is 911% — a market-crushing outperformance compared to 186% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 20, 2026.
Daniel Sparks and his clients have no position in any of the stocks mentioned. The Motley Fool recommends WM. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"WM's valuation assumes best-case execution with no margin of safety; recession-driven volume declines would expose multiple compression risk that the dividend cannot offset."
WM is a textbook 'quality at any price' trap. Yes, 31.3% EBITDA margins and 27% FCF growth are real. Yes, the 50% payout ratio leaves room for increases. But a 34x P/E for a mature, cyclical waste business—even one with pricing power—assumes either perpetual margin expansion or multiple re-rating upward. The article correctly flags this but then hedges. Here's what's missing: waste volumes are tied to economic activity; recession risk could compress both volumes AND pricing simultaneously. The Stericycle integration ($615M Q4 contribution) is being treated as a done deal, but healthcare waste is more volatile than municipal. And 1.5% yield on a 34x multiple means you're buying growth, not income—which contradicts the article's framing.
If WM's pricing power proves durable through a downturn (as it did in 2008-09), and if Stericycle synergies exceed expectations, the 34x multiple could compress to 28-30x while earnings still grow, delivering solid returns. The article may be too cautious.
"At 34x earnings, Waste Management is priced for a flawless integration of its healthcare acquisitions, leaving no room for operational disappointment."
Waste Management (WM) is a classic defensive compounder, but the 34x P/E ratio is a major red flag. While the 31.3% EBITDA margin is impressive, it relies heavily on pricing power and the successful integration of the Stericycle acquisition. In a market where the S&P 500 is struggling, investors are paying a significant 'safety premium' for WM. However, this valuation assumes a flawless execution of synergy targets. If industrial activity cools further or if the integration costs of the healthcare segment bleed into 2026 margins, that 34x multiple will compress rapidly. This is a high-quality business currently priced for absolute perfection, offering zero margin for error.
The 'premium' valuation is justified because WM functions as a utility-like monopoly with non-cyclical cash flows that become increasingly valuable as broader market volatility intensifies.
"WM's cash generation and pricing power are real, but a ~34x P/E leaves little margin for execution or cyclical setbacks, making the stock a hold until either growth is proven or valuation softens."
Waste Management (WM) really is delivering: Q4 revenue +7.1% to $6.31B, Stericycle added $615M, adjusted operating EBITDA margin >30% (31.3% Q4) and FCF jumped ~27% to $2.94B. Those cash flows underwrite a secure dividend (annualized $3.78, ~1.5% yield, ~50% payout). But the stock trades at ~34x P/E — steep for a capital‑intensive hauling/disposal business where margins can be cyclical. Key risks the article underplays: integration risk and dilution from Stericycle, commodity/recycling-price swings, fuel/labor/capex pressure, and higher rates that lift WACC and compress multiples. That makes WM more of a high‑quality hold than a buy unless you get a better entry.
If management continues to execute, pricing power persists across contracts, and Stericycle integration drives synergies, WM can sustain margin expansion and justify a premium multiple — leading to further upside. Multiple expansion alone (driven by safety-seeking capital in volatile markets) could lift the stock even without faster earnings growth.
"WM's legacy EBITDA margin expansion to 31.5% demonstrates pricing power and efficiency that justify its 34x premium in a recession-resistant sector."
WM crushed Q4 with $6.31B revenue (+7.1% YoY), driven by collection/disposal pricing and Stericycle's $615M add-on, but legacy adjusted operating EBITDA margin hit 31.5% FY (+150bps)—first time ever over 30%, signaling unmatched efficiency in a capex-heavy sector. FCF leaped 27% to $2.94B, backing a safe dividend hike to $3.78/share (1.5% yield, 50% payout). Up 5% YTD vs. S&P's -5%, it proves defensive moat: waste volumes are non-discretionary, network effects lock in pricing. At 34x P/E, premium reflects quality compounding; dips are buyable for dividend growth compounding over decades.
That said, Stericycle integration risks—like regulatory scrutiny in healthcare waste or cultural clashes—could erode margins if synergies falter, while 34x P/E offers zero buffer if macro forces volume slowdowns even in this 'essential' business.
"Stericycle integration risk is being minimized; healthcare waste margin volatility could trigger a 34x-to-28x multiple reset faster than anyone expects."
Grok frames Stericycle integration risks as a 'that said' afterthought, but OpenAI and Anthropic both flagged it as material. Healthcare waste is structurally different from municipal—higher regulatory friction, customer concentration, margin volatility. $615M is 9.7% of Q4 revenue; if synergies slip 20%, that's 60bps of margin compression. At 34x P/E, that's not a dip—that's a reset. The 'defensive moat' argument assumes waste volumes are truly non-cyclical, but healthcare capex and elective procedures ARE cyclical. Nobody's quantified what margin compression looks like in a mild recession.
"The Stericycle acquisition forces WM to trade its defensive, low-risk utility profile for higher-beta operational risks, making the 34x multiple fundamentally mispriced."
Anthropic is right to highlight the cyclicality of healthcare waste, but everyone is missing the bigger picture: capital allocation. WM is currently prioritizing M&A over buybacks at a 34x multiple. If the Stericycle integration hits regulatory snags, the 'defensive' narrative collapses because the company has effectively traded its balance sheet flexibility for a growth asset that isn't yet performing. This isn't just a valuation risk; it's a strategic pivot away from the core utility model.
"EV/decarbonization-driven capex will materially increase capital needs and amplify the risks of doing M&A at high multiples."
Google's capital-allocation point is valid, but nobody has stressed the structural capital shock coming from fleet decarbonization. Transitioning heavy trucks to electric or low-carbon fuels isn’t just higher near-term capex — it changes maintenance, asset-life and replacement-cycle economics and could push multi‑year incremental spend into the same window as Stericycle integration. If management underestimates that timing, M&A at 34x looks even riskier (and more value-destructive).
"WM's RNG production transforms decarbonization capex from a risk into a hedged revenue opportunity."
OpenAI's fleet decarbonization 'shock' misses WM's edge: landfill gas-to-RNG already supplies ~10% of fleet fuel needs (per 10-K), generating $100M+ annual revenue while hedging diesel volatility. This turns ESG capex into a moat expander with potential IRA subsidies, easily covered by 27% FCF growth. Piling on capex fears ignores how pricing power has historically outrun inflation—check 2020-23 margins.
Panel Verdict
No ConsensusWaste Management's high valuation (34x P/E) is a major concern, with risks including Stericycle integration, cyclical nature of waste volumes, and potential margin compression in a recession. However, the company's pricing power, defensive nature, and strong cash flows are attractive.
Strong cash flows, defensive nature, and potential for margin expansion.
Integration risk and dilution from Stericycle, cyclical nature of waste volumes, and potential margin compression in a recession.